Skip to main content

Phase 3 randomized, open-label study to evaluate Eflornithine with Lomustine compared to Lomustine (STELLAR) alone in patients with Anaplastic Astrocytoma

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Orbus Therapeutics, Inc.

Start Date

October 1, 2016

End Date

July 15, 2022
 

Administered By

Duke Cancer Institute

Awarded By

Orbus Therapeutics, Inc.

Start Date

October 1, 2016

End Date

July 15, 2022